Navigation Links
Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports

(PRWEB) June 28, 2012

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provide free online informational resources that deal with the potential dangers of using certain prescription medications, hereby alerts the public that an Actos bladder cancer lawsuit has been filed in Louisiana by a woman who alleges that her use of this diabetes medication led to her contracting bladder cancer.

Specifically, the case has been assigned a case number of 6:12-cv-1701 and it names several defendants in the action. These defendants include Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. The case was filed on June 14th in the U.S. District Court for the Western District of Louisiana and is assigned to Judge Rebecca Doherty.

This Actos bladder cancer lawsuit alleges that the plaintiff used Actos between the years of 2004 and 2007. The plaintiff was diagnosed with bladder cancer in 2006, and she alleges that the prolonged use of Actos is what led to this diagnosis. As a result of this diagnosis, the plaintiff alleges that she has incurred damages that include past and future medical costs, past and future pain and suffering, past and future emotional distress and the loss of companionship with her spouse.

Actos is a diabetes medication that is prescribed for people to help them treat their symptoms associated with type 2 diabetes, and in recent years the medication has been banned in both France and Germany and the United States Food and Drug Administration has required warnings to be published on the labels of this medication that alert its users of the potential risks involving bladder cancer for those who use it for a prolonged period of time.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Chemo + Radiation Best for Bladder Cancer, Study Finds
4. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
5. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
6. Study Ties Secondhand Smoke to Bladder Irritation in Kids
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
9. Study Suggests Vaccine May Help Kids With Brain Cancer
10. New Stool Test Might Aid in Early Detection of Colon Cancer
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: